iShares Nasdaq Biotechnology (IBB)

Add to Watchlists
Create an Alert
296.15 +0.60  +0.20% NASDAQ Apr 26, 13:32 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Key Stats

Expense Ratio 0.47%
Share Class Assets Under Management 8.072B
30-Day Average Daily Volume Upgrade
Net Asset Value 295.68
Discount or Premium to NAV -0.04%
Turnover Ratio 24.00

IBB Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.89% 0.62% 27
3M 8.50% 9.07% 64
6M 11.61% 9.45% 35
1Y 12.70% 6.37% 82
3Y 7.63% 9.57% 64
5Y 19.16% 16.63% 17
As of April 25, 2017
Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.01% 0.02% 0.01%
Stock 99.99% 99.99% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of April 24, 2017

IBB Region Exposure

Americas 98.14%
North America 98.14%
Latin America 0.00
Greater Europe 1.33%
United Kingdom 0.59%
Europe Developed 0.69%
Europe Emerging 0.00
Africa/Middle East 0.06%
Greater Asia 0.52%
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.52%
Market Classification
% Developed Markets 99.48%
% Emerging Markets 0.52%
As of April 21, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.94%
Industrials 0.00
Real Estate 0.00
Technology 0.06%
Utilities 0.00
As of April 24, 2017

IBB Stock Market Capitalization

Giant 15.58%
Large 45.19%
Medium 15.84%
Small 14.29%
Micro 9.10%
As of April 24, 2017

IBB Stock Style Exposure

Large Cap Value 21.64%
Large Cap Blend 8.07%
Large Cap Growth 33.35%
Mid Cap Value 0.00
Mid Cap Blend 0.00
Mid Cap Growth 15.98%
Small Cap Value 0.67%
Small Cap Blend 3.30%
Small Cap Growth 16.99%
As of April 24, 2017
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
CELG Celgene Corp 8.09% 125.32 -0.16%
BIIB Biogen Inc 7.78% 280.37 -2.27%
GILD Gilead Sciences Inc 7.62% 68.46 +2.00%
AMGN Amgen Inc 7.50% 164.49 -0.13%
REGN Regeneron Pharmaceuticals Inc 6.34% 372.06 -0.07%
VRTX Vertex Pharmaceuticals Inc 4.86% 116.41 -0.73%
ILMN Illumina Inc 4.37% 182.90 +0.77%
INCY Incyte Corp 3.78% 123.82 -0.46%
ALXN Alexion Pharmaceuticals Inc 3.69% 122.00 +1.20%
MYL Mylan NV 3.33% 37.51 +1.79%
As of April 24, 2017
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 0.96 yrs
Diane Hsiung 9.25 yrs
Greg Savage 9.25 yrs
Jennifer Hsui 4.67 yrs

IBB Net Fund Flows

1M 177.21M
3M -63.57M
6M 677.50M
YTD -63.57M
1Y 1.195B
3Y 2.496B
5Y 3.727B
10Y 3.649B
As of March 31, 2017

IBB Risk Info

Beta (5Y) 1.223
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.7796
Historical Sortino (All) 0.5616
30-Day Rolling Volatility 15.19%
Daily Value at Risk (VaR) 1% (All) 4.89%
Monthly Value at Risk (VaR) 1% (All) 19.75%

IBB Fundamentals

Dividend Yield TTM (4-26-17) 0.22%
SEC Yield (12-31-15) 0.00%
Weighted Average PE Ratio 20.83
Weighted Average Price to Sales Ratio 5.940
Weighted Average Price to Book Ratio 4.980
Weighted Median ROE 9.86%
Weighted Median ROA -2.13%
Forecasted Dividend Yield 0.58%
Forecasted PE Ratio 20.60
Forecasted Price to Sales Ratio 4.086
Forecasted Price to Book Ratio 3.831
Number of Holdings 164
As of April 24, 2017

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 7.15%
Forecasted Book Value Growth 16.93%
Forecasted Cash Flow Growth 16.69%
Forecasted Earnings Growth 13.30%
Forecasted Revenue Growth 15.62%
As of April 24, 2017

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Last Annual Report Date 3/31/2016
Last Prospectus Date 8/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.